These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 3116555)
1. Randomised, double-blind study of estramustine phosphate and leuprolide acetate. De la Grange AB Prog Clin Biol Res; 1987; 243B():227-8. PubMed ID: 3116555 [No Abstract] [Full Text] [Related]
2. French multicenter study on the use of estramustine phosphate versus diethylstilbestrol. Hauchecorne J Prog Clin Biol Res; 1987; 243B():229-34. PubMed ID: 3309983 [No Abstract] [Full Text] [Related]
3. Estramustine phosphate vs diethylstilbestrol in the treatment of stage D prostate cancer. Benson RC; Cummings K Prog Clin Biol Res; 1989; 303():177-86. PubMed ID: 2674984 [No Abstract] [Full Text] [Related]
4. [Hormone therapy of male genital cancer (prostatic cancer)]. Machida T; Ikemoto I Gan To Kagaku Ryoho; 1987 Oct; 14(10):2845-52. PubMed ID: 2444164 [TBL] [Abstract][Full Text] [Related]
5. Mode of action of estramustine phosphate in hormone dependent and hormone non-dependent prostate cancer. Hedlund PO Prog Clin Biol Res; 1985; 185A():197-202. PubMed ID: 3898129 [No Abstract] [Full Text] [Related]
6. Combined androgen blockade: leuprolide and flutamide versus leuprolide and placebo. Crawford ED; Goodman P; Blumenstein B Semin Urol; 1990 Aug; 8(3):154-8. PubMed ID: 2119048 [No Abstract] [Full Text] [Related]
7. A current review of the clinical experience with Estracyt. Murphy GP Prog Clin Biol Res; 1987; 243B():221-5. PubMed ID: 3309982 [No Abstract] [Full Text] [Related]
8. Estracyt--mode of action and clinical experience. Hedlund PO Prog Clin Biol Res; 1987; 243B():215-9. PubMed ID: 3309981 [No Abstract] [Full Text] [Related]
9. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. Crawford ED; Eisenberger MA; McLeod DG; Spaulding JT; Benson R; Dorr FA; Blumenstein BA; Davis MA; Goodman PJ N Engl J Med; 1989 Aug; 321(7):419-24. PubMed ID: 2503724 [TBL] [Abstract][Full Text] [Related]
10. Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate. Nickel CJ; Morales A Can J Surg; 1983 Sep; 26(5):434-8. PubMed ID: 6351988 [TBL] [Abstract][Full Text] [Related]
11. Leuprolide for prostate cancer. Med Lett Drugs Ther; 1985 Aug; 27(694):71-2. PubMed ID: 2410765 [No Abstract] [Full Text] [Related]
12. [Treatment of hormone-resistant prostate cancer with estramustine phosphate (Estracyt)]. Stridsklev IC; Fosså SD; Kaalhus O Tidsskr Nor Laegeforen; 1984 Oct; 104(28):1977-80. PubMed ID: 6388019 [No Abstract] [Full Text] [Related]
13. [Serum testosterone and acid phosphatase levels in patients with prostatic cancer treated with Estracyt]. Németh A; Morvay J; Vécsei B Orv Hetil; 1981 Apr; 122(17):1017-20. PubMed ID: 7022313 [No Abstract] [Full Text] [Related]
14. A randomized double blind crossover trial of diethylstilbestrol (DES) and estramustine phosphate (Emcyt) for stage D prostatic carcinoma. Benson RC; Gill GM; Cummings KB Semin Oncol; 1983 Sep; 10(3 Suppl 3):43-5. PubMed ID: 6364366 [No Abstract] [Full Text] [Related]
15. The EORTC Phase III trials in prostatic cancer. Robinson MR; Smith PH; Macaluso MP; Sylvester R; de Voogt H Prog Clin Biol Res; 1985; 185A():243-9. PubMed ID: 3898132 [No Abstract] [Full Text] [Related]
16. Leuprolide: a review of its effects in comparison with diethylstilboestrol in the treatment of advanced cancer of the prostate. Garnick MB; Glode LM; Smith JA; Max DT Br J Clin Pract; 1985 Feb; 39(2):73-6. PubMed ID: 3921047 [No Abstract] [Full Text] [Related]
17. [Cellular immunity in prostatic cancer modified by Cytonal, Estrazyt and Turisteron]. Klebingat KJ; Panzig E; Lorenz G; Steinhauser I; Fiedler R Z Urol Nephrol; 1987 Mar; 80(3):139-47. PubMed ID: 3300097 [TBL] [Abstract][Full Text] [Related]
18. [What is safe in the therapy of advanced prostatic cancer?]. Gropp C; Burk K Internist (Berl); 1985 Dec; 26(12):765-70. PubMed ID: 3936819 [No Abstract] [Full Text] [Related]
19. The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiation. Murphy GP; Gibbons RP; Johnson DE; Prout GR; Schmidt JD; Soloway MS; Loening SA; Chu TM; Gaeta JF; Saroff J; Wajsman Z; Slack N; Scott WW Trans Am Assoc Genitourin Surg; 1978; 70():69-71. PubMed ID: 753026 [TBL] [Abstract][Full Text] [Related]